CORTICOSTEROIDS AND FIBROLYSIN IN THE PREVENTION OF LACRIMAL DUCT OBSTRUCTION.
Dayal
Y
Y
Gandhi Eye Hospital and M.U. Institute of Ophthalmology, Aligarh, India.
D000293:Adolescent; D000305:Adrenal Cortex Hormones; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage*; D007223:Infant; D007766:Lacrimal Apparatus Diseases / Q000517:prevention & control*; D007767:Lacrimal Duct Obstruction / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009301:Nasolacrimal Duct / Q000187:drug effects*; D012980:Sodium Salicylate / Q000008:administration & dosage*; D013890:Thiourea / Q000008:administration & dosage* / Q000031:analogs & derivatives; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; C009842:allylthiourea; D013890:Thiourea; D006854:Hydrocortisone; D012980:Sodium Salicylate